Clinical Trial Update: Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reporting on the safety, tolerability, and pharmacokinetics of ATB-346 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• ATB-346

Snippet

Sponsor: Antibe Therapeutics Inc. | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED